Sun, S. et al. Nat Commun. 12, 5654 (2021)
SARS-CoV-2, which relies on cellular receptor angiotensin-converting enzyme 2 (ACE2) to enter host cells, cannot infect standard laboratory mice due to differences in amino acid residues between mouse and human ACE2. In Nature Communications, Sun et al. report the generation of a lethal mouse-adapted SARS-CoV-2 for studying COVID-19 pathogenesis in mice.
Varying doses of mouse-adapted SARS-CoV-2 strain MASCp36 — a strain generated by further passaging of previously described MASCp6 — were intranasally inoculated in young, old female and male mice. In infected mice, MASCp36 caused severe respiratory symptoms, massive macrophages and neutrophils infiltration, high levels of proinflammatory cytokines, as well age- and gender-specific responses, resembling the clinical manifestations of severe COVID-19 in humans.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Le Bras, A. A new lethal mouse-adapted SARS-CoV-2 for COVID research. Lab Anim 51, 7 (2022). https://doi.org/10.1038/s41684-021-00900-1
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41684-021-00900-1